$4.45
-0.04 (-0.89%)
RVSN News14 articles
Snap Shares Dip as User Valuation Trails Rivals; Australia Regulatory Pressure Mounts
Snap shares declined Monday amid valuation concerns and fresh regulatory risks from Australia. The company's market cap per user lags behind rivals like Pinterest and Meta.
Bradesco Preferred Shares Trail Sector Rally as Trading Volume Spikes
Bradesco preferred shares gained 2.6% last week, underperforming the Ibovespa's 3.0% rise. Over half of weekly trading volume occurred on two days when the stock fell.
XRP Slips Below $1.10 as ETF Net Assets Trail Inflows by $459M
XRP fell 2.4% to $1.07, with U.S. spot ETF net assets $459 million below total inflows, as ETF buying failed to offset broader market selling.
Becerra Takes Early Lead in California Governor Race, Trump-Backed Hilton Trails
Democrat Xavier Becerra leads Republican Steve Hilton by 21 points among registered voters, according to a UC Berkeley IGS poll, with official results to be certified by July 10.
SGH Shares Trail ASX 200 Rally Ahead of FY26 Earnings Report
SGH shares gained 0.70% to A$41.51, underperforming the ASX 200's 1.98% jump. The next catalyst is FY26 earnings on August 11, with an analyst target of A$47.64.
STB Pauses $85B Rail Merger, Demands More Data from Union Pacific and Norfolk Southern
The STB accepted Union Pacific and Norfolk Southern's revised merger filing but paused the case, demanding more information by July 27. Shares fell 4.2% and 5.4%.
L.B. Foster Stock Nears 52-Week High Amid Robust Rail Revenue Growth
L.B. Foster shares neared a 52-week high after Q1 net sales rose 23.9%, led by rail revenue growth of 38.4%. The stock has more than doubled from its low.
DraftKings Surges as Railbird Exchange Certifies Sports Event Contracts with CFTC
DraftKings shares rose 5.3% to $25.07 after Railbird Exchange certified six sports event-contract templates with the CFTC, marking a key step into federally regulated prediction markets.
Stryker Stock Drops 6.5% as Cyberattack Derails Q1 Earnings; 2026 Targets Remain
Stryker shares dropped 6.5% after Q1 earnings missed estimates due to a March cyberattack. Revenue was $6.0B vs $6.35B expected, but 2026 guidance remains unchanged.
Lilly's Oral Obesity Drug Foundayo Trails Novo Nordisk's Wegovy in Early Prescription Data
Eli Lilly's Foundayo prescriptions hit 3,707 in week two, well behind Novo Nordisk's Wegovy. Lilly shares dropped 4%, while Novo gained 6%. Analysts advise caution on early figures.
Netskope Launches AI Security Guardrails Ahead of Key Earnings Report
Netskope has made its AI Guardrails product generally available, positioning the launch just before its March 11 AI event and Q4 earnings report. The company aims to help businesses secure generative AI use.
Grail Shares Halve as UK Trial Misses Primary Endpoint, Clouding FDA Path
GRAIL Inc. shares plummeted almost 50% in Friday trading following disappointing results from a major UK study of its multi-cancer early detection test. The trial's failure to hit its primary endpoint complicates the company's regulatory and reimbursement strategy.
Siemens Gains on Major Copenhagen Rail Contract Ahead of Key Earnings Week
Siemens shares advanced 2.45% following a €3 billion automated train contract win in Copenhagen. Investors now focus on upcoming Q1 results and a proposed €5.35 dividend.
Communication Services Sector Trails Market Rally Amid AI Spending Concerns
The Communication Services Select Sector SPDR Fund (XLC) declined 0.39% on Friday, underperforming the S&P 500's 1.97% gain. Key holdings like Alphabet and Meta fell as investors weigh heavy AI-related capital expenditures.